Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Status and Forecast 2018-2025
This report studies the Amyotrophic Lateral Sclerosis (ALS) Treatment market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top company in global and major regions, and splits the Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type and applications/end industries.
In the last several years, global market of Amyotrophic Lateral Sclerosis (ALS) Treatment developed smoothly, with an average growth rate of 21% during 2013 to 2018. The principal reason was contribution made by Radicava, which was launched in the USA in August 2017. And Radicava has gotten off to a strong start. In 2017, global revenue of Amyotrophic Lateral Sclerosis (ALS) Treatment is nearly 197 million USD.
The major players in global Amyotrophic Lateral Sclerosis (ALS) Treatment market include
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Geographically, this report is segmented into several key regions, with production, sales, revenue, market share and growth rate of Amyotrophic Lateral Sclerosis (ALS) Treatment in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
South America
Rest of World
On the basis of product, the Amyotrophic Lateral Sclerosis (ALS) Treatment market is primarily split into
Riluzole
Edaravone (Radicava)
Other
On the basis on the end users/applications, this report covers
Hospital
Drugs Store
Other
- 1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025)
- 1.4.2 Riluzole
- 1.4.3 Edaravone (Radicava)
- 1.5 Market by Application
- 1.6 Study Objectives
- 1.7 Years Considered
- 2 Global Growth Trends
- 2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size
- 2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Regions
- 2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2013-2025)
- 2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2013-2018)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
- 3 Market Share by Key Players
- 3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Manufacturers
- 3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018)
- 3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Manufacturers (2017-2018)
- 3.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5)
- 3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served
- 3.3 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service
- 3.4 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
- 4 Breakdown Data by Type and Application
- 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018)
- 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018)
- 5 North America
- 5.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in North America
- 5.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 5.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 6 Europe
- 6.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Europe
- 6.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 6.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 7 China
- 7.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in China
- 7.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 7.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 8 Japan
- 8.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Japan
- 8.3 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 8.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 9 Southeast Asia
- 9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 9.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 10 India
- 10.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 10.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in India
- 10.3 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 10.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 11 South America
- 11.1 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market (2013-2018)
- 11.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in South America
- 11.3 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
- 11.4 South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
- 12 Analysis of Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Key Manufacturers
- 12.1 Mitsubishi Tanabe Pharma
- 12.1.1 Company Profile
- 12.1.2 Product Information
- 12.1.3 Revenue and Gross Margin
- 12.2 Sanofi
- 12.2.1 Company Profile
- 12.2.2 Product Information
- 12.2.3 Revenue and Gross Margin
- 12.3 Mylan Pharma
- 12.3.1 Company Profile
- 12.3.2 Product Information
- 12.3.3 Revenue and Gross Margin
- 12.4 Apotex
- 12.4.1 Company Profile
- 12.4.2 Product Information
- 12.4.3 Revenue and Gross Margin
- 12.5 Glemark Generics
- 12.5.1 Company Profile
- 12.5.2 Product Information
- 12.5.3 Revenue and Gross Margin
- 12.6 Covis Pharma
- 12.6.1 Company Profile
- 12.6.2 Product Information
- 12.6.3 Revenue and Gross Margin
- 12.7 Sun Pharma
- 12.7.1 Company Profile
- 12.7.2 Product Information
- 12.7.3 Revenue and Gross Margin
- 12.8 Lunan Pharma
- 12.8.1 Company Profile
- 12.8.2 Product Information
- 12.8.3 Revenue and Gross Margin
- 13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 North America
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
- 14 Analyst's Viewpoints/Conclusions
- 15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
- 15.3 Author Details
- List of Table and Figure
- Table Amyotrophic Lateral Sclerosis (ALS) Treatment Key Market Segments
- Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Covered
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2013-2025) (M USD)
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2018
- Figure Riluzole Features
- Table of Key Players of Riluzole
- Figure Edaravone (Radicava) Features
- Table of Key Players of Edaravone (Radicava)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (2013-2025) (M USD)
- Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size and Growth Rate 2013-2025 (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2025 (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2013-2018 (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2013-2018
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions 2018
- Table Market Drivers
- Figure Global GDP Growth Rate for 2016
- Figure Real GDP Growth 2016-2020 Annual Average
- Figure USA GDP 2008-2016 (Billion USD)
- Figure USA GDP Growth Rate Change 2015-2018
- Figure EU GDP 2008-2016 (Billion USD)
- Figure EU GDP Growth Rate Change 2015-2018
- Figure Germany GDP 2008-2016 (Billion USD)
- Figure Germany GDP Growth Rate 2015-2018
- Figure UK GDP 2008-2016 (Billion USD)
- Figure UK GDP Growth Rate 2015-2018
- Figure Italy GDP 2008-2016 (Billion USD)
- Figure Italy GDP Growth Rate 2015-2018
- Figure France GDP 2008-2016 (Billion USD)
- Figure France GDP Growth Rate 2015-2018
- Figure Japan GDP 2008-2016 (Billion USD)
- Figure Japan GDP Growth Rate 2015-2018
- Figure China GDP 2008-2016 (Billion USD)
- Figure China GDP Growth Rate 2015-2018
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2017-2018) (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers (2017-2018)
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2017
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Manufacturers in 2018
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturers Market Concentration Ratio (CR5)
- Table Key Players Head office and Area Served
- Table Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service
- Table Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Type (2013-2018)
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2013-2018)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Application (2013-2018)
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2013-2018)
- Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application in 2018
- Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table North America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table Europe Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table China Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table Japan Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table Southeast Asia Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table India Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Figure South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2013-2018 (M USD)
- Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2017-2018) (M USD)
- Table South America Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2017-2018)
- Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2013-2018) (M USD)
- Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2013-2018)
- Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2013-2018) (M USD)
- Table South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2013-2018)
- Table Mitsubishi Tanabe Pharma Company Profile
- Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mitsubishi Tanabe Pharma
- Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mitsubishi Tanabe Pharma 2017-2018
- Table Sanofi Company Profile
- Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Sanofi
- Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Sanofi 2017-2018
- Table Mylan Pharma Company Profile
- Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Mylan Pharma
- Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Mylan Pharma 2017-2018
- Table Apotex Company Profile
- Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture of Apotex
- Table Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (M USD) and Gross Margin of Apotex 2017-2018 58
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
